Search...
Tianjin Development's subsidiary subscribes to a financial product worth 50 million yuan
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Tianjin Development announced that on June 19, 2025, Lifeng Pharmaceutical (an indirectly non-wholly-owned subsidiary of the company) entered into the ninth wealth management agreement with Xingyin Wealth Management and Industrial Bank, subscribing to another fixed-income investment product with a principal amount of RMB 50 million
According to the announcement from Tianjin Development (00882), on June 19, 2025, Lisheng Pharmaceutical (the company's indirectly non-wholly-owned subsidiary) entered into the ninth wealth management agreement with Xingyin Wealth Management and Industrial Bank, subscribing to another fixed-income investment product with a principal amount of RMB 50 million
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments